Gastric cancer: Clinical Practice Guidelines in oncology™

Jaffer Ajani; Tanios Bekaii-Saab; Thomas A. D'Amico; Charles Fuchs; Michael K. Gibson; Melvyn Goldberg; James A. Hayman; David H. Ilson; Milind Javle; Scott Kelley; Robert C. Kurtz; Gershon Yehuda Locker; Neal J. Meropol; Bruce D. Minsky; Mark B. Orringer; Raymond U. Osarogiagbon; James A. Posey; Jack Roth; Aaron R. Sasson; Stephen G. Swisher; Douglas E. Wood; Yun Yen

doi:10.6004/jnccn.2006.0030

Gastric cancer: Clinical Practice Guidelines in oncology™

Jaffer Ajani, Tanios Bekaii-Saab, Thomas A. D'Amico, Charles Fuchs, Michael K. Gibson, Melvyn Goldberg, James A. Hayman, David H. Ilson, Milind Javle, Scott Kelley, Robert C. Kurtz, Gershon Yehuda Locker, Neal J. Meropol, Bruce D. Minsky, Mark B. Orringer, Raymond U. Osarogiagbon, James A. Posey, Jack Roth, Aaron R. Sasson, Stephen G. SwisherDouglas E. Wood, Yun Yen

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Abstract

Gastric cancer is rampant in several countries worldwide. Its incidence in the Western hemisphere has been declining for more than 40 years; however, the location of gastric cancer has shifted proximally in the past 15 years. The reason for this shift is unclear. Diffuse histology is also more common now than intestinal type of histology. Advances have been made in staging procedures, such as laparoscopy and endoscopic ultrasonography, and in possible functional imaging techniques. The current TNM classification requires an examination of at least 15 lymph nodes; a DO dissection is unacceptable. Patients with locoregional gastric carcinoma should also be referred to high-volume treatment centers. Combination chemotherapy and radiotherapy in the adjuvant setting for a select group of patients is the new standard in the United States. These guidelines provide a uniform systematic approach to gastric cancer in the United States. Investigation results for new chemotherapeutic agents, including antireceptor agents, vaccines, gene therapy, and antiangiogenic agents, and many future advances in the treatment of gastric carcinoma are anticipated.

Original language	English (US)
Pages (from-to)	350-366
Number of pages	17
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	4
Issue number	4
DOIs	https://doi.org/10.6004/jnccn.2006.0030
State	Published - Apr 2006

Keywords

Chemoradiation
Chemotherapy
Combined modality therapy
Gastric carcinoma
NCCN Clinical Practice Guidelines
Resection
Surgery

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2006.0030

Cite this

Ajani, J., Bekaii-Saab, T., D'Amico, T. A., Fuchs, C., Gibson, M. K., Goldberg, M., Hayman, J. A., Ilson, D. H., Javle, M., Kelley, S., Kurtz, R. C., Locker, G. Y., Meropol, N. J., Minsky, B. D., Orringer, M. B., Osarogiagbon, R. U., Posey, J. A., Roth, J., Sasson, A. R., ... Yen, Y. (2006). Gastric cancer: Clinical Practice Guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 4(4), 350-366. https://doi.org/10.6004/jnccn.2006.0030

Ajani, J, Bekaii-Saab, T, D'Amico, TA, Fuchs, C, Gibson, MK, Goldberg, M, Hayman, JA, Ilson, DH, Javle, M, Kelley, S, Kurtz, RC, Locker, GY, Meropol, NJ, Minsky, BD, Orringer, MB, Osarogiagbon, RU, Posey, JA, Roth, J, Sasson, AR, Swisher, SG, Wood, DE & Yen, Y 2006, 'Gastric cancer: Clinical Practice Guidelines in oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 4, no. 4, pp. 350-366. https://doi.org/10.6004/jnccn.2006.0030

@article{113f39779a3a48449300bf3ecb5cf985,

title = "Gastric cancer: Clinical Practice Guidelines in oncology{\texttrademark}",

abstract = "Gastric cancer is rampant in several countries worldwide. Its incidence in the Western hemisphere has been declining for more than 40 years; however, the location of gastric cancer has shifted proximally in the past 15 years. The reason for this shift is unclear. Diffuse histology is also more common now than intestinal type of histology. Advances have been made in staging procedures, such as laparoscopy and endoscopic ultrasonography, and in possible functional imaging techniques. The current TNM classification requires an examination of at least 15 lymph nodes; a DO dissection is unacceptable. Patients with locoregional gastric carcinoma should also be referred to high-volume treatment centers. Combination chemotherapy and radiotherapy in the adjuvant setting for a select group of patients is the new standard in the United States. These guidelines provide a uniform systematic approach to gastric cancer in the United States. Investigation results for new chemotherapeutic agents, including antireceptor agents, vaccines, gene therapy, and antiangiogenic agents, and many future advances in the treatment of gastric carcinoma are anticipated.",

keywords = "Chemoradiation, Chemotherapy, Combined modality therapy, Gastric carcinoma, NCCN Clinical Practice Guidelines, Resection, Surgery",

author = "Jaffer Ajani and Tanios Bekaii-Saab and D'Amico, {Thomas A.} and Charles Fuchs and Gibson, {Michael K.} and Melvyn Goldberg and Hayman, {James A.} and Ilson, {David H.} and Milind Javle and Scott Kelley and Kurtz, {Robert C.} and Locker, {Gershon Yehuda} and Meropol, {Neal J.} and Minsky, {Bruce D.} and Orringer, {Mark B.} and Osarogiagbon, {Raymond U.} and Posey, {James A.} and Jack Roth and Sasson, {Aaron R.} and Swisher, {Stephen G.} and Wood, {Douglas E.} and Yun Yen",

year = "2006",

month = apr,

doi = "10.6004/jnccn.2006.0030",

language = "English (US)",

volume = "4",

pages = "350--366",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "4",

}

TY - JOUR

T1 - Gastric cancer

T2 - Clinical Practice Guidelines in oncology™

AU - Ajani, Jaffer

AU - Bekaii-Saab, Tanios

AU - D'Amico, Thomas A.

AU - Fuchs, Charles

AU - Gibson, Michael K.

AU - Goldberg, Melvyn

AU - Hayman, James A.

AU - Ilson, David H.

AU - Javle, Milind

AU - Kelley, Scott

AU - Kurtz, Robert C.

AU - Locker, Gershon Yehuda

AU - Meropol, Neal J.

AU - Minsky, Bruce D.

AU - Orringer, Mark B.

AU - Osarogiagbon, Raymond U.

AU - Posey, James A.

AU - Roth, Jack

AU - Sasson, Aaron R.

AU - Swisher, Stephen G.

AU - Wood, Douglas E.

AU - Yen, Yun

PY - 2006/4

Y1 - 2006/4

N2 - Gastric cancer is rampant in several countries worldwide. Its incidence in the Western hemisphere has been declining for more than 40 years; however, the location of gastric cancer has shifted proximally in the past 15 years. The reason for this shift is unclear. Diffuse histology is also more common now than intestinal type of histology. Advances have been made in staging procedures, such as laparoscopy and endoscopic ultrasonography, and in possible functional imaging techniques. The current TNM classification requires an examination of at least 15 lymph nodes; a DO dissection is unacceptable. Patients with locoregional gastric carcinoma should also be referred to high-volume treatment centers. Combination chemotherapy and radiotherapy in the adjuvant setting for a select group of patients is the new standard in the United States. These guidelines provide a uniform systematic approach to gastric cancer in the United States. Investigation results for new chemotherapeutic agents, including antireceptor agents, vaccines, gene therapy, and antiangiogenic agents, and many future advances in the treatment of gastric carcinoma are anticipated.

AB - Gastric cancer is rampant in several countries worldwide. Its incidence in the Western hemisphere has been declining for more than 40 years; however, the location of gastric cancer has shifted proximally in the past 15 years. The reason for this shift is unclear. Diffuse histology is also more common now than intestinal type of histology. Advances have been made in staging procedures, such as laparoscopy and endoscopic ultrasonography, and in possible functional imaging techniques. The current TNM classification requires an examination of at least 15 lymph nodes; a DO dissection is unacceptable. Patients with locoregional gastric carcinoma should also be referred to high-volume treatment centers. Combination chemotherapy and radiotherapy in the adjuvant setting for a select group of patients is the new standard in the United States. These guidelines provide a uniform systematic approach to gastric cancer in the United States. Investigation results for new chemotherapeutic agents, including antireceptor agents, vaccines, gene therapy, and antiangiogenic agents, and many future advances in the treatment of gastric carcinoma are anticipated.

KW - Chemoradiation

KW - Chemotherapy

KW - Combined modality therapy

KW - Gastric carcinoma

KW - NCCN Clinical Practice Guidelines

KW - Resection

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=33747132697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747132697&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2006.0030

DO - 10.6004/jnccn.2006.0030

M3 - Review article

C2 - 16569388

AN - SCOPUS:33747132697

SN - 1540-1405

VL - 4

SP - 350

EP - 366

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 4

ER -

Gastric cancer: Clinical Practice Guidelines in oncology™

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this